Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayR J Bio-Tech Ltd 2CINL24234MH2005PLC158420 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 36.11 4Highest Credit Rating during the previous FY BWRBB+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)BRICKWORK RATINGS INDIA PRIVATE LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Anand Designation: CompanySecretary EmailId: cs@rjbiotech.com Name of the Chief Financial Officer: Aarti Designation: Chieffinancialofficer EmailId: aarti@khadkeshwara.com Date: 27/05/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.